BioCentury
ARTICLE | Company News

GSK, Epizyme in histone methyltransferases deal

January 11, 2011 2:24 AM UTC

Epizyme Inc. (Cambridge, Mass.) partnered with GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) to discover, develop and commercialize small molecule therapeutics targeting histone methyltransferases for cance...